Background: Patients with a right-sided (R) and/or KRAS-mutated (KRAS-MUT) primary tumors have inferior outcomes compared to patients with left sided (L) and/or KRAS-wildtype (KRAS-WT) cancers.

Medtronic announced that the first patient has been treated in its SPYRAL GEMINI global pilot study, which will investigate the saf ...

Hepatic artery infusion (HAI) therapy offers a new approach for people whose colorectal cancer has spread to the liver. It allows physicians to deliver chemotherapy directly to the liver at doses up ...

Hepatic Artery Infusion (HAI) therapy is a powerful way to administer chemotherapy directly to tumors in the liver, resulting in up to 400 times greater drug concentration in the tumors than is ...

A handful of people are the core of your team for hepatic artery infusion (HAI) therapy. You will have a surgeon and medical oncologist experienced with this highly specialized treatment. You will ...

In the article that accompanies this editorial, Li et al 1 conducted a randomized controlled trial in patients with large hepatocellular carcinoma and found that hepatic artery infusion chemotherapy ...